The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis.  The fourteen patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy.  The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-00536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Wrongful death litigation for a pro bono client
Represented a widow in a wrongful death suit against a railroad company arising from the derailment of an Amtrak passenger train in South Carolina. A more
Syndicated credit facility provided by a major U.S. financial institution
Represented a major U.S. financial institution, as administrative agent and lender, in connection with the provision of $110,000,000 secured more
Transactions for brokerage firms
Represented one of the leading U.S.-based brokerage firms in commercial loan transactions for its brokerage customers; loans secured by real and more
Tax advice for international financial structuring
Represented a multinational manufacturing company, in developing and implementing European financing, holding company and repatriation structures to more